Abstract:PURPOSE:Estrogen receptor alpha (ER alpha) mediates the growth stimulation of estrogen in breast cancer cells and is a useful predictive factor for response to endocrine therapy. It is reported that ER alpha was induced in ER alpha negative breast cancer cells by both DNA methyltransferase-1 (DNMT1) inhibitor 5-aza-2'-deoxycytidine (AZA) and histone deacetylase (HDAC) inhibitor trichostatin A (TSA). However, whether the breast cancer cells with induced ER alpha restore response to endocrine therapy requires to be further researched. PATIENTS AND METHODS:Reverse transcriptase-polymerase chain reaction (RT-PCR) method was used to explore the change in the mRNA of ER alpha, PR and pS2 in the ER alpha negative breast cancer cells MDA-MB-435 treated with two chemicals (AZA + TSA). Water-soluble tetrazolium salt-8 (WST-8) method was used to study the proliferation rate of the breast cancer cells. Flow cytometer (FCW) was used to analyze the distribution of cell cycle of these breast cancer cells. Some xenograft models in nude mice were used to further study the results we found in vitro. RESULTS:In this study we observed that the mRNA of ER alpha, PR and pS2 in the ER alpha negative breast cancer cells MDA-MB-435 was re-expressed by treatment with AZA + TSA. The proliferation assay analysis showed AZA + TSA suppressed the proliferation of MDA-MB-435 cells, which were further suppressed by addition of 4-OH Tamoxifen (4-OHT). On the contrary, the proliferation of cells treated with 4-OHT alone showed no difference compared with the vehicle control. Cell cycle analysis showed AZA + TSA treated cells showed S phase arrest, which was partially attenuated by addition of estradiol (E2); furthermore, the effect of E2 on stimulation of cell cycle could be reversed by 4-OHT in the treated cells with induced ER alpha. In vivo experiment xenograft volume of MDA-MB-435 cells treated with AZA + TSA was smaller than that of the control (P < 0.01), and the xenograft of AZA + TSA treated cells was further suppressed by ovariectomy (P < 0.01). CONCLUSIONS:Our data indicate that DNMT1 inhibitor AZA and HDAC inhibitor TSA play important roles in restoring sensitivity of the ER alpha negative breast cancer cells to endocrine therapy in vitro and in vivo.

The Study on Chemical Suppression of Proliferation of MDA-MB-435 Through AZA and TSA

The effects of 5-Aza-2-deoxycytidine, a methylation inhibitor, on the proliferation of androgen-sensitive prostate cancer cell line, and on the regulation of methylation of glutathione s-transferase P1 and retinoic acid receptorβ2 gene

Effect of 5-Azn-2'-deoxycytidine on Proliferation of Human Lung Adenocarcinoma Cell Line A549 in Vitro

ERα negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor

ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor.

Molecular Mechanisms of Trichostatin A Inhibiting the Proliferation of Breast Cancer Cells

3-MA combined with TSA inhibits growth of triple-negative breast cancer cells

HDAC Inhibitor TSA Induced Apoptosis and Growth Arrest in Breast Cancer Cells

Experimental study of apoptosis of human breast cancer MDA-MB-231 cell line induced by AZD2281

Transcription Regulation of Gene Expression of Human Sex Hormone Receptors in Breast Cancer Cells Induced by 5-Aza-dc and Trichostatin A

Epigenetic Regulation in Combination with Endocrine Therapy Reducing the Proliferation of NCI-H1975 Cells

Trichostatin A Inhibits Proliferation and Induces Expression of P21waf and P27 in Human Brain Tumor Cell Lines.

[Expression of ER Alpha in Chemically Induced MDA-MB-435 Cells and Its Responsiveness to Endocrine].

Research of Trichostatin A in Treating Bladder Cancer

Pi3k/Mtor Dual Inhibitor Bez235 and Histone Deacetylase Inhibitor Trichostatin A Synergistically Exert Anti-Tumor Activity in Breast Cancer

Synergistic effect of trichostatina A combined with all-trans retinoic acid on induction of apoptosis of cervical cancer SiHa cells

Trichostatin A Inhibits Proliferation of Triple Negative Breast Cancer Cells by Inducing Cell Cycle Arrest and Apoptosis.

Effects of 5-Aza-dc Combined with TSA on MGMT Expression and NF-κB Activity in Gastric Cancer Cell Line SGC-7901

Mechanism of trichostatin A combined with all-trans retinoic acid on HeLa cells

The Growth Inhibitory Effect of Trichostatin A on Non-Small Cell Lung Cancer A549 Cells and Its Mechanisms

Effect of Suberoyl Bishydroxamic Acid on the Proliferation of Breast Cancer Cells